Decreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan [1]

PO-REN HSUEHShyr J.-M.Wu J.-J.2020-12-182020-12-1820051058-4838https://scholars.lib.ntu.edu.tw/handle/123456789/528875[SDGs]SDG3azithromycin; clarithromycin; erythromycin; roxithromycin; antibiotic resistance; antibiotic sensitivity; bacterium isolate; government regulation; health care policy; hospital bed capacity; human; infection rate; infection resistance; letter; medical assessment; medical documentation; priority journal; reimbursement; Streptococcus pyogenes; upper respiratory tract infection; Anti-Bacterial Agents; Documentation; Drug Resistance, Bacterial; Drug Utilization; Erythromycin; Humans; National Health Programs; Reimbursement Mechanisms; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pyogenes; TaiwanDecreased erythromycin use after antimicrobial reimbursement restriction for undocumented bacterial upper respiratory tract infections significantly reduced erythromycin resistance in Streptococcus pyogenes in Taiwan [1]letter10.1086/427946157360302-s2.0-14944345006